Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Psoriasis Treatment Center of Central New Jersey
East Windsor, New Jersey, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Recent positive results from open-label trial of tapinarof cream in combination with biologics showed 52% of patients achieved treat-to-target goal of ≤1% body surface area, with 75% reduction in PASI scores maintained even after discontinuation
- Therapeutic areas
- OncologyDermatologyImmunology
- Modalities
- Small moleculeBiologic
- Industry
- Academic Hospital/University/Research
02
Partnerships
Target PharmaSolutions
Beyond the preview
Go deeper on Psoriasis Treatment Center of Central New Jersey.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Psoriasis Treatment Center of Central New Jersey.